-
New breakthrough in cancer-targeted drug screening
Time of Update: 2021-02-06
To confirm that the chemicals identified in the initial large-scale screening were indeed reliable and repeatable, the NCATS team needed to use a variety of bio-chemical methods to confirm the activity of each compound.
-
Studies warn that some drugs may have side effects on the lungs
Time of Update: 2021-02-06
Some drugs used to treat a variety of diseases, including cancer, may have side effects on the lungs, and the effects are greater than previously thought, according to a new study published by the University of Manchester.
-
Targeting special proteins is expected to completely cure melanoma
Time of Update: 2021-02-06
Melanoma is a malignant skin cancer that kills about 9,000 people a year in the United States; in the paper, researchers delved into missing proteins that play a key role in the NGLY1 defect, which is so rare that there are only about 60 patients with the disease worldwide since the disease was diagnosed in 2012; and when researchers delved into the genetic disorder, they found that melanoma cells may be highly susceptible to NGLY1 deficiency.
-
Fissin gel has been approved by the FDA for breakthrough therapy for low-risk upper urinary tract skin cancer
Time of Update: 2021-02-06
UroGen, a biopharmaceutical company focused on the clinical phase of urological oncology that addresss unsepped medical needs in the field of urology, announced on October 30 that the U.S. FDA has awarded the company's main drug candidate, UGN-101 (Syrizctomycin Gel), a breakthrough therapy designation.
-
New research has found key proteins that affect asthma
Time of Update: 2021-02-06
A protein that plays a key role in regulating allergic airway inflammation could help find better asthma treatments in the future, according to a new study published by the Francis Crick Institute in the UK.
-
New progress has been made in the targeted treatment of atherosclerosis
Time of Update: 2021-01-30
In this way, Liao Xiaoling's research team, in collaboration with Professor Wang Gui of Chongqing University, used a bionic design strategy to wrap macrophage membranes on nanopics, and constructed the bionic nanopic drugs MM/RAPNPs with drug slow release, long-acting blood circulation and active targeting of atherosclerosis drug delivery.
-
Chinese and foreign scholars in Nanjing focus on immunology to promote innovative drug research and development
Time of Update: 2021-01-30
chen Shana, director of Inner Mongolia International Mongolian Medical Hospital, said that based on the characteristics of WeChat's convenient application, networked hospitals can enable patients to complete online appointment registration, network consultation, follow-up consultation, report inquiries, online drug withdrawal, health management and other medical services, according to different medical needs to choose video, voice, picture and other forms, to achieve no contact between doctors and patients, "zero distance" communication.
-
China's pharmaceutical companies independently develop new cancer drugs on the market
Time of Update: 2021-01-30
Chinese Academy of Sciences academician Chen Kaixian 23, told reporters that the listing of Sutaida ® not only for China's non-pancreatic neuroendocrine tumor targeted treatment to provide drug solutions, but also shows that China's innovative drugs are cutting-edge innovative research concepts, standardized research and development processes to accelerate the benefits of Chinese patients, to the world.
-
New progress has been made in the pharmacologically active ingredient of Lianhua Qing plague capsule against neocoopon pneumonia
Time of Update: 2021-01-30
Pharma Network January 26 - Recently, Professor Wu Caisheng of Xiamen University School of Pharmacy, in cooperation with Professor Chai Yifeng of the Naval Military Medical University, made new progre
-
3 billion injections! Hesco has commented on the rush of stone medicine, Howson and so on
Time of Update: 2021-01-29
Source: MED2.0 China Drug Review Database Up to now, 7 enterprises have been evaluated for injection of Esomeladium sodium, of which, Zhengda Tianqing Pharmaceutical Group, Jiangsu Osaikang Pharmaceuticals, Langtian Pharmaceuticals, Jiangsu Zhengda Fenghai Pharmaceuticals, Liaoning Haisco Pharmaceuticals were approved for supplementary applications, Chongqing Lemei Pharmaceuticals, Hunan Seron Pharmaceuticals with imitation 4 categories of declaration approved, as reviewed.
-
Qilu has another class of new drugs to attack the first oral dissolved membrane will be approved
Time of Update: 2021-01-24
Pharma Network January 12th, January 9th, Qilu Pharmaceuticals Class 1 new drug injection QLS31901 clinical application was accepted by CDE contractor, acceptance number CXSL2100012.
-
Has the incubation period for new coronavirus been extended? Listen to what the experts have to say
Time of Update: 2021-01-24
" on January 13 held a joint press conference of the State Council, for Dalian infected people in 4 nucleic acid tests only found, and its in vivo virus incubation period of more than 10 days, Beijing University First Hospital infection department director Wang Guiqiang said that the new crown virus incubation period is extended, need further research.
-
Chinese scholars have taken the lead in clarifying the molecular genetic mechanism associated with SLE morbidity
Time of Update: 2021-01-24
Reporters learned on the 9th, Shanghai Jiaotong University School of Medicine affiliated Renji Hospital Rheumatology Research Institute Professor Shen Nan team took the lead in the SLE autoimmune disease risk genetic variation and the cause of the link, expounded in the lupus disease in the key path of the key regulatory role of non-coding RNA-related molecular genetic mechanism, for the treatment provides a new direction and target.
-
Tianjin University's research and development of "cluster enzyme" is expected to bring good news to patients with neuroinflammation
Time of Update: 2021-01-24
Medical Network January 12, a few days ago, Tianjin University Medical Department Zhang Xiaodong team successfully designed a new type of artificial enzyme - "cluster enzyme." "cluster enzyme" has super catalytic activity and selectivity, the potential for the treatment of alzheimer's disease, brain injury and other neuro-inflammation is huge, the results have been published online in the international authoritative journal Nature Communications.
-
Multiple large varieties, over-consistent evaluation (with list)
Time of Update: 2021-01-23
1.6 billion varieties, the first review according to the NMPA released the news, Colon Pharmaceuticals medium / long chain fat emulsion (C8-24) the first through a consistent evaluation, the product is an extraintestinal nutrition drug.
-
The application for the listing of Qilu Pharmaceutical's Aiqupa ethanolamine tablets was accepted by CDE contractors
Time of Update: 2021-01-22
meters of intranet data show that in 2019, China's urban physical pharmacy terminal Ayquopa ethanolamine tablet sales reached 170 million yuan, up 289.63 percent year-on-year, forecast 2020 sales will reach 290 million yuan, up 67.92 percent year-on-year, replacing injection recombinant human coagulation factor VIII., became the best-selling anti-hemostamine drugstore drugstore.
-
Fourtean drug varieties entered the clinical real-world data application pilot in Boao Lecheng Pre-City District
Time of Update: 2021-01-14
" Hainan clinical real-world data application pilot work, help to further promote the international advanced pharmaceutical products to accelerate access to the Chinese market, for domestic patients to provide more choices for drug use, but also to enable more Chinese patients to benefit from innovative drugs and medical devices.
-
China's vaccine research and development work has always been in the world's first square
Time of Update: 2021-01-14
The State Drug Administration approved the conditional listing of the new coronavirus inactivated vaccine of China National Pharmaceutical Corporation in Beijing on December 30.
-
Candidate drug modification variant Diabetes treatment drug development research has made important progress
Time of Update: 2021-01-14
show that it has excellent blood sugar lowering, weight loss effect and good drug." research has applied for national invention patents and international patent protection, and has reached preliminary intention with a number of enterprises to jointly promote clinical trials and industrialization.
-
The Guangdong Provincial Center for Disease Control and Prevention has successfully isolated a new strain of coronavirus in South Africa
Time of Update: 2021-01-13
December 31, the Guangdong Provincial Center for Disease Control and Prevention received samples of case pharynx swabs collected by the Eighth People's Hospital of Guangzhou City, immediately carried out virus isolation and gene sequencing analysis, on the evening of January 5, 2021, through the re-review and identification of the original samples and virus isolation cultures, the virus genome sequence belongs to the B.1.351 subtype, the tip is 501Y.V2 South African mutant strain.
